Immunotherapy - the science of harnessing the immune system to fight human disease - has transformed medicine in the past decade.

Yet the interactions between the immune system and the rest of the body are extremely complex and hinder the development of many immunotherapeutic interventions. Weizmann Center for Immunotherapy is bringing together world-leading research and clinical teams in single-cell genomics, AI and antibody engineering in order to overcome this complexity and unleash the full potential of immunotherapy in dealing with autoimmune, cancer, neurodegeneration and inflammatory diseases.

The center provides state-of-the-art single cell research platform, advanced pipelines to develop, characterize and optimize novel antibody-based immunotherapies and a wide spectrum of AI-empowered computational models for immunotherapy applications. The center gives WIS researchers the opportunity to rapidly scale and expand their scientific achievements toward precision drug development and clinical outcomes.

Director

Prof. Ido Amit

Principal Investigator

“You don’t learn to walk by following rules. You learn by trying and falling over.” Husband, dad and enthusiast mountain-biker.

Weizmann Institute of Science

The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to 3,700 scientists, students, technicians, and supporting staff. The Institute's research efforts include searching for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.